SCHEMBL14096678

SCHEMBL14096678

Cc1cc2c3c(c4c(c2cc1C)-c1ccc(C(=O)c2cccc5ccccc25)cc1C41c2ccccc2-c2ccccc21)C1(c2ccccc2-c2ccccc21)c1cc(C(=O)c2cccc4ccccc24)ccc1-3

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BCL2L1 Q07817 1/20 0.42
▸ CNR2 P34972 10/20 0.40
▸ BCL2 P10415 1/20 0.39
▸ MCL1 Q07820 1/20 0.39
▸ BAD Q92934 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.37
▸ ESR1 P03372 1/20 0.37
▸ ESR2 Q92731 1/20 0.37
▸ CDC25B P30305 2/20 0.37
▸ H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 P62805 1/20 0.37
▸ EP300 Q09472 1/20 0.37
▸ PRMT1 Q99873 1/20 0.37
▸ PLK1 P53350 1/20 0.36
▸ PDK2 Q15119 1/20 0.36
▸ CNR1 P21554 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ NR1I2 O75469 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13423253 0.89 BCL2 (0.44) CNR2BCL2MCL1BADCDC25B
SCHEMBL14096680 0.87 ALDH1A1 (0.40) CNR2ALDH1A1ESR1ESR2PDK2
SCHEMBL14096679 0.85 PDK2 (0.50) BCL2L1CNR2ALDH1A1ESR1ESR2
SCHEMBL15780097 0.85 BCL2L1 (0.32) BCL2L1CNR2BCL2MCL1BAD
SCHEMBL19292257 0.77 PDK2 (0.33) ALDH1A1PDK2
SCHEMBL19292407 0.76 PDK2 (0.42) CNR2ALDH1A1PDK2MEN1CYP1A2
SCHEMBL132972 0.76 ALDH1A1 (0.48) ALDH1A1ESR1ESR2CDC25BPDK2
SCHEMBL13781074 0.75 BCL2 (0.41) CNR2BCL2MCL1BADCDC25B
SCHEMBL14073397 0.75 CNR2 (0.45) CNR2BCL2MCL1BADCDC25B
SCHEMBL17084377 0.74 CNR2 (0.47) CNR2BCL2MCL1BADCDC25B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3211058-B1 NEW MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2023-08-23 — — EP disclosed
EP-3211058-A1 NEW MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES Merck Patent GmbH (DE) 2017-08-30 — — EP disclosed
US-8748010-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2014-06-10 — — US disclosed
US-20080193797-A1 Novel Materials for Organic Electroluminescent Devices MERCK PATENT GMBH (DE) 2008-08-14 — — US disclosed
US-20080193797-A1 Novel Materials for Organic Electroluminescent Devices MERCK PATENT GMBH (DE) 2008-08-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080193797-A1 Novel Materials for Organic Electroluminescent Devices SLC40A1, SLC67A1, SLC29A1 BCL2L1 2170/4885CNR2 3910/4885BCL2 4454/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback